AB4AD logo

AB4AD
AB4AD (Antibodies for Alzheimer's Disease)

0
Mkt Cap
$44,356.00
24H Volume
$17.76
FDV
$44,356.00
Circ Supply
1M
Total Supply
1M
AB4AD Fundamentals
Max Supply
1M
7D High
$0.0463
7D Low
$0.0444
24H High
$0.00
24H Low
$0.00
All-Time High
$0.3762
All-Time Low
$0.0443
AB4AD Prices
AB4AD / USD
$0.0444
AB4AD / EUR
€0.0376
AB4AD / GBP
£0.0329
AB4AD / CAD
CA$0.0607
AB4AD / AUD
A$0.0627
AB4AD / INR
₹4.02
AB4AD / NGN
NGN 59.55
AB4AD / NZD
NZ$0.0742
AB4AD / PHP
₱2.57
AB4AD / SGD
SGD 0.0562
AB4AD / ZAR
ZAR 0.7115
Loading...
Loading...
News
all
press releases
<
...
1
>

Sentiment

Indicates whether most users posting on a symbol’s stream over the last 24 hours are fearful or greedy.
0
25
50
75
100
Extreme
Fear
Neutral
Greed
Extreme
Fear
Greed
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

Message Volume

Measures the total amount of chatter on a stream over the last 24 hours.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

Participation Ratio

Measures the number of unique accounts posting on a stream relative to the number of total messages on that stream.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

AboutAb4AD (Antibodies for Alzheimer’s Disease) is a research initiative from Dr. Daniel Z. Bar (Tel Aviv University) that investigates the pathogen hypothesis of Alzheimer’s: common infections (notably herpes and P. gingivalis) appear to modulate AD risk. The team will analyze blood and saliva from dementia-free elderly individuals and compare them to AD patients and younger controls to identify protective antibodies. Instead of only targeting protein aggregation, Ab4AD focuses on why some exposed individuals stay dementia-free, using their natural antibody profiles as blueprints for protection. Funded and tracked through Molecule Catalyst, enabling visible milestones and community governance via IP Tokens (IPTs).
Details
Links
Source
Categories
Base EcosystemDecentralized Science (DeSci)
Date
Market Cap
Volume
Close
February 23, 2026
$44,356.48
$17.76
$0.0444
February 22, 2026
$44,356.48
$17.76
$0.0444
February 22, 2026
$46,285.35
$18.69
$0.0467
February 21, 2026
$46,702.24
$18.49
$0.0462
February 05, 2026
$48,668.60
$718.64
$0.0487
February 04, 2026
$47,858.91
$706.61
$0.0479
February 03, 2026
$90,705.54
$626.98
$0.0907
February 02, 2026
$121,510.04
$8.50
$0.1215
February 01, 2026
$127,844.12
$9.74
$0.1273
January 31, 2026
$127,844.12
$9.74
$0.1273

Poll

If symbol logo$BTC drops 20% tomorrow, what are you doing?
Buying more
Holding
Trimming
Panic selling

Latest AB4AD News

Top Discussions

Advertisement|Remove ads.